Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma-derived von Willebrand factor

被引：0
|
作者：
Tran, Thuy B. [1 ]
Arnall, Justin R. [1 ]
Kleiboer, Brendan [2 ]
Hinson, Ashley [2 ]
机构：
[1] Atrium Hlth, Dept Pharm, Specialty Pharm Serv, 4400 Golf Acres Dr,Bldg J,Suite B1, Charlotte, NC 28208 USA
[2] Atrium Hlth, Levine Childrens Canc & Blood Disorder, Levine Canc Inst, Charlotte, NC USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷 / 02期
关键词：
DESENSITIZATION;
D O I：
10.1002/pbc.29918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
    Castaman, Giancarlo
    Linari, Silvia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1029 - 1037
  • [32] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN PAEDIATRIC PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Borel-Derlon, A.
    Henriet, C.
    Repesse, Y.
    Susen, S.
    HAEMOPHILIA, 2023, 29 : 147 - 147
  • [33] Immunogenicity of a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate during the Wil-31 Prophylaxis Study in Patients with Von Willebrand Disease
    Khayat, Claudia Djambas
    Robert, Sidonio F., Jr.
    Pavlova, Anna
    BLOOD, 2023, 142
  • [34] TREATMENT WITH A PLASMA-DERIVED VON WILLEBRAND FACTOR (VWF) ALMOST DEVOID OF FACTOR VIII IN ELDERLY PATIENTS WITH VON WILLEBRAND DISEASE (VWD): A POOLED ANALYSIS
    Goudemand, J.
    Derlon, A. Borel
    Henriet, C.
    Susen, S.
    Repesse, Y.
    HAEMOPHILIA, 2022, 28 : 109 - 110
  • [35] The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
    Martin Büchsel
    Ulrich Geisen
    Clara Beckenkamp
    Tobias Wengenmayer
    Barbara Zieger
    Dirk Westermann
    Patrick M. Siegel
    Thrombosis Journal, 21
  • [36] PHARMACOKINETICS (PK) OF VON WILLEBRAND FACTOR (VWF) IN PATIENTS WITH VON WILLEBRAND DISEASE (VWD) AFTER TREATMENT WITH RECOMBINANT VWF OR PLASMA-DERIVED VWF CONCENTRATE.
    Wang, Y.
    Marier, J.
    Vasilinin, G.
    Berthoz, F. Truong
    Azen, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S36 - S37
  • [37] The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome - an observational study
    Buechsel, Martin
    Geisen, Ulrich
    Beckenkamp, Clara
    Wengenmayer, Tobias
    Zieger, Barbara
    Westermann, Dirk
    Siegel, Patrick M.
    THROMBOSIS JOURNAL, 2023, 21 (01)
  • [38] The Effect of Age on von Willebrand Factor and Bleeding Symptoms in von Willebrand Disease
    Seaman, Craig D.
    Ragni, Margaret, V
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (08) : 1159 - 1165
  • [39] von Willebrand disease and von Willebrand factor
    Sadler, Brooke
    Castaman, Giancarlo
    O'Donnell, James S.
    HAEMOPHILIA, 2022, 28 : 11 - 17
  • [40] von Willebrand Factor and von Willebrand Disease
    王兆钺
    血栓与止血学, 2005, (04) : 147 - 149
12345